After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension
- PMID: 38754980
- DOI: 10.1093/ehjcvp/pvae035
After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
